The artificial Insemination Market is expanding at a robust pace with a rapidly increasing infertility rate and continuous research and development activities

 

Artificial insemination or in vitro fertilization is the intentional introduction of sperms into a woman's uterus or cervix for the intent of becoming pregnant via in vitro fertilization, other than sexual contact. This process is often referred to as intrauterine insemination, which involves the use of a needle or some other method to insert the sperms. It is one of the most effective ways to help women who have had no success with natural childbirth and who are attempting childbirth after having suffered a cesarean section. As far as regional impact is concerned, North America seems to be gaining significant traction in the artificial insemination market. This is typically due to the fact that there are technological advancements and favorable rules and regulations in the region. On the contrary, Asia Pacific is registering lucrative demand for artificial insemination kits due to growing prevalence of infertility in the region.

Infertility in women is one of the most concerning health problems and is highly prevalent across the globe. According to the World Bank, the fertility rate in 2018 was 2.415 births per woman, decreasing from 2.555 in 2008. The rapidly declining fertility rate in both developed and emerging economies has led to increased demand for infertility drugs. Generally, infertility is caused by problems with ovulation, while some problems stop an egg from being released at all. As a result of this, the demand for artificial insemination has increased. Hence, such factors can stimulate growth of the artificial insemination market.

There are many factors that go into determining a fertility treatment's success rates. One of the most important factors is actually the ability of the man to produce sperm at all. If a man can produce sperm at all, then he can be considered a good candidate for artificial insemination. Good sperm production means that a man's chances of getting his partner pregnant will be high. Regardless of these advantages, there are certain factors that remain one of the major challenges. For instance, stringent regulations being implemented in many countries on fertility treatment is likely to impede the artificial insemination market growth.

Many families are increasingly preferring Planned Parenthood due to uninterrupted full-time professional careers. Besides, key companies operating in the market are focused on optimizing the operational efficiency of the production and supply chain. This involves new product launches and continuous research and development activities. Therefore, such factors can potentially augment growth of the artificial insemination market in the near future. Recently, in July 2019, Vitrolife AB collaborated with Prime Tech to develop and exclusively market the Piezo technique for improved intracytoplasmic sperm injection (ICSI) procedures in humans globally.